Nutrients Rx Lab Work Deep Dives

Each Deep Dive Panel is designed to reveal the nuances of endocrine function that are often missed by standard laboratory testing. By offering thyroid, female hormone, and male hormone panels individually, practitioners gain access to highly specific data that allows for more accurate assessment and targeted intervention.

Thyroid Panel

The thyroid panel goes beyond TSH-only testing by measuring free T4, free T3, reverse T3, and thyroid antibodies (TPO and thyroglobulin). This allows practitioners to evaluate not just gland output, but also hormone conversion, tissue utilization, and immune activity against thyroid tissue. Identifying issues like impaired T4-to-T3 conversion, elevated reverse T3, or antibody-driven autoimmunity provides insight into conditions such as Hashimoto’s thyroiditis, subclinical hypothyroidism, or stress-related thyroid suppression—conditions that are frequently overlooked in conventional care.

Female Hormone Panel

The female hormone panel evaluates the interplay between the ovaries, adrenal glands, and pituitary signaling. Measuring estradiol, progesterone, testosterone, DHEA, LH, FSH, prolactin, SHBG, and the Free Androgen Index provides a full-spectrum view of reproductive and adrenal hormone dynamics. This panel is particularly valuable for uncovering estrogen dominance, luteal phase defects, androgen excess (common in PCOS), and perimenopausal transitions. By mapping how each hormone interacts across the HPGA (hypothalamic-pituitary-gonadal-adrenal) axis, clinicians can distinguish between ovarian insufficiency, adrenal-driven hormone imbalances, and pituitary regulation issues—leading to more precise and effective protocols.

Male Hormone Panel

The male hormone panel offers a complete picture of androgen balance and regulation. With measurements of total testosterone (mass spectrometry), estradiol, DHEA, LH, FSH, prolactin, SHBG, and the Free Androgen Index, practitioners can determine whether low testosterone is due to testicular underproduction (primary hypogonadism) or pituitary dysfunction (secondary hypogonadism). In addition, the inclusion of estradiol and SHBG highlights aromatization and hormone-binding dynamics, which are critical in cases of metabolic dysfunction, cardiovascular risk, or declining vitality. This panel helps practitioners understand how hormonal imbalances may be driving fatigue, weight gain, mood disturbances, or reduced performance in male patients.

Together, these panels provide a systems-level perspective on endocrine health. Rather than isolated snapshots, the Deep Dive Panels reveal how thyroid, adrenal, pituitary, and gonadal pathways work together—or against each other—to create patient symptoms. This integrative approach equips practitioners with the precise data they need to build targeted, individualized protocols that restore balance and optimize long-term outcomes.

D-Dimer

D-dimer is a fibrin degradation product used to assess active clot formation and breakdown in the body. Elevated levels suggest increased thrombotic activity and may be seen in conditions such as venous thromboembolism, disseminated intravascular coagulation, infection, inflammation, or recent surgery or trauma. While a normal D-dimer can help rule out acute thrombotic events in low-risk patients, elevations are nonspecific and must be interpreted in clinical context. This marker is best used as part of a broader risk and symptom assessment rather than as a standalone diagnostic test.

Troponin T, High-Sensitivity

High-sensitivity troponin T is a cardiac-specific biomarker used to detect myocardial injury. Even minor elevations can reflect subtle cardiac stress, ischemia, inflammation, or structural heart strain, not solely acute myocardial infarction. This assay allows for earlier detection and improved risk stratification when interpreted alongside symptoms, ECG findings, and clinical history. Persistently elevated or rising values warrant further cardiovascular evaluation.

Insulin

Fasting insulin provides insight into insulin sensitivity and early metabolic dysfunction. Elevated levels may indicate insulin resistance, often preceding abnormalities in fasting glucose or hemoglobin A1c. This marker is useful for identifying cardiometabolic risk and guiding early lifestyle or therapeutic interventions before overt diabetes develops. Interpretation is strongest when paired with fasting glucose to calculate the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR).

Cortisol, AM

Morning cortisol reflects adrenal output at the expected circadian peak. This test is most informative when collected between 6:00–10:00 AM, ideally near the patient’s usual waking time. Abnormally low values may suggest adrenal insufficiency or hypothalamic-pituitary-adrenal (HPA) axis suppression, while elevated levels can be associated with chronic stress, inflammation, or hypercortisol states. Results should be interpreted in clinical context, and additional testing may be required to assess diurnal rhythm or dynamic adrenal function.

Homocysteine

Homocysteine is an amino acid linked to cardiovascular, neurologic, and endothelial health. Elevated levels are associated with increased risk of atherosclerosis, thrombosis, and cognitive decline and may reflect functional deficiencies in folate, vitamin B12, or vitamin B6. This marker is useful for identifying modifiable cardiometabolic and neurovascular risk. Targeted nutritional and lifestyle interventions may help normalize levels.

GlycA

GlycA is a composite biomarker reflecting systemic inflammation based on glycosylated acute-phase proteins. It provides a stable measure of chronic inflammatory burden and is less affected by short-term fluctuations than markers like CRP. Elevated GlycA levels are associated with increased cardiometabolic and all-cause mortality risk. This test is useful for long-term risk stratification and monitoring response to interventions.

Carbohydrate Antigen (CA) 19-9

CA 19-9 is a tumor-associated antigen most commonly used as a monitoring marker in pancreatic and hepatobiliary malignancies. Elevated levels can also occur in benign conditions such as biliary obstruction, pancreatitis, or liver disease. This test is not intended for cancer screening in asymptomatic individuals. Interpretation should always consider clinical findings and imaging results.